ACTOLIND^® SOLUTION PLUS

Actolind products (Solution and Gel) can be used on open lesions or wounds caused by eczema to help prevent infection, cleanse the affected area, and support faster healing by keeping the wound moist. However, these products are not eczema creams or scar-removal treatments. They are not intended to eliminate fully healed scars beneath the skin or to treat the underlying cause of eczema.

No, it does not cause a burning or painful sensation. Thanks to its alcohol-free and tissue-friendly formulation, it is fully compatible with mucous membranes and sensitive tissues. It does not cause irritation, burning, or discomfort during application, allowing dressing changes to be carried out comfortably and painlessly.

Yes, it can be highly beneficial. One of the main factors preventing long-standing chronic wounds from healing is the presence of resistant bacteria and biofilm. The Poloxamer in Actolind Solution (or Solution Plus) helps remove biofilm and necrotic tissue, while PHMB helps control infection and initiates the wound’s natural healing process (granulation).

For elderly patients who are not suitable candidates for surgery, it can help reduce the burden of wound care and support safe wound management.

Yes, it can. Particularly for deep, cavitary wounds or wounds with narrow openings, the solution can be drawn from the bottle using a sterile syringe and applied directly to the wound bed for pressurized irrigation. The product’s 5 ml and 10 ml single-use Monodose Strip ampoules are also a practical alternative for this purpose.

Both product lines contain the same main active ingredients (PHMB and Poloxamer) and are intended for similar purposes. Solution Plus contains an additional surfactant, which lowers surface tension (34.42 mN/m) and improves its wetting and cleansing performance.

Although both products are highly effective for foot wounds, Actolind Solution Plus may be preferred particularly for resistant wounds with heavy biofilm, crusting, or difficult drainage, due to its lower surface tension.

Yes, they can be safely used in all of these areas.

Burns: They are among the preferred options for cleansing and moisturizing first- and second-degree thermal, chemical, and friction burns.

Pressure Ulcers: They are effective for cleansing stage 2, 3, and 4 pressure ulcers and protecting the wound with gel.

PEG and Catheter Care: They are indicated for cleansing the peristomal skin (the area around the PEG tube) and catheter insertion sites, as well as helping protect these areas from infection.

Difference between W Gel and Gel Plus: Both contain PHMB (0.1%) and Poloxamer. Gel Plus contains an additional surfactant and has a higher viscosity and greater moisturizing capacity.

Difference between Solution and Gel: Solution is a liquid formulation used to irrigate and cleanse the wound bed and remove debris and biofilm. Gel has a thicker consistency and is applied to the cleansed wound to coat the wound surface, maintain a moist environment, protect it from external factors, and prevent the dressing from adhering to the wound.

Ingredient Added to the Enhanced Formulation: As a result of R&D studies, a special surfactant component has been added that further reduces the surface tension of the gel/solution and enhances spreading and moisturization.

Actolind W Gel Ingredients: Water, Poloxamer, Polyhexanide (PHMB, 0.1%), and excipients.

Actolind Gel Plus Ingredients: Water, Poloxamer, Polyhexanide (PHMB, 0.1%), an additional surfactant component, and excipients.

No, it is not intended for this purpose. Actolind Solution Plus is not a scar-removal solution. Its primary function is to cleanse open wounds, such as surgical incision wounds, remove necrotic tissue and bacteria, and help prevent the risk of infection. Once the sutures have been removed and the wound has completely closed, scar creams containing active ingredients such as silicone are more appropriate.

No, its use is not recommended. Actolind Solution Plus is a Class III medical wound irrigation and cleansing solution. Its active ingredients, PHMB and Poloxamer, are designed solely to reduce the microbial load in the open wound bed and remove biofilm. It is not intended for use on intact skin to reduce superficial cosmetic marks or as a toner or skincare solution.

It primarily consists of water, Polyhexanide (PHMB, 0.1%), and Poloxamer; it also contains an additional surfactant specific to the Plus series.

Its primary function is to cleanse and irrigate the wound surface, moisturize the wound, reduce the microbial load, and provide wound care.

Both series contain the same active ingredients and have the same intended uses. The Plus series takes this one step further by more effectively reducing surface tension through the additional surfactant component incorporated into its formulation, thereby enhancing spreading and cleansing performance.

PHMB is a broad-spectrum cationic antimicrobial agent. It binds to the bacterial membrane, disrupts membrane permeability, and inactivates microorganisms.

Poloxamer is a non-ionic surfactant. By reducing surface tension, it facilitates the mechanical detachment and removal of dirt, debris, and biofilm layers from the wound bed.

Poloxamer reduces surface tension, facilitating access to and loosening contaminants; PHMB then inactivates the exposed microorganisms.

The pH value ranges from 5.0 to 7.5.

The surface tension of Actolind Solution Plus (34.42 mN/m) is significantly lower than that of comparable products containing hypochlorite or PHMB + betaine. This allows it to penetrate wound crevices much more effectively.

No. Due to its large polymeric structure, it does not enter the systemic circulation, is not absorbed, and does not accumulate in tissues.

No. According to CARC and international assessments, it has no carcinogenic, toxic, or genotoxic effects on human health.

It can be used for all acute and chronic wounds, whether infected or non-infected, as well as for first- and second-degree burns.

Yes. It is used to help prevent surgical site infections and for the irrigation of surgical wounds.

Yes. It is used as a first-line option for the irrigation and cleansing of thermal, flame, friction, and chemical burns.

Yes. It is indicated for the irrigation of open wounds caused by electrical injury and radiation.

It reduces the microbial load of the wound, facilitates the debridement of necrotic tissue, and eliminates the risk of infection.

It is used for the thorough cleansing of cavitary and necrotic pressure ulcers, the elimination of malodor, and the removal of biofilm.

Yes, it is ideal for the irrigation of leg ulcers, softening of crusts, and preparation of the granulation bed.

Yes, it can be safely used at urological catheter insertion sites and for the care of peristomal skin, fistulas, and abscesses.

Yes, it is clinically effective for the irrigation of contaminated traumatic wounds with tissue loss, such as bites, crush injuries, and avulsion injuries.

Yes, it is compatible with mucosal tissues and does not cause irritation or a burning sensation.

No, rinsing is not required.

It is applied by pouring it directly onto the wound, spraying it onto the wound, or wiping the wound with gauze compresses soaked in the solution.

For deep wounds with extensive necrosis, it is recommended to leave a gauze compress soaked in the solution on the wound for at least 60 seconds (or 10–15 minutes depending on clinical need) as a wet dressing.

Yes, it can be warmed to body temperature before use for patient comfort.

When dried dressings and gauze that have adhered to the wound are thoroughly soaked with Actolind Solution Plus, they soften and can be easily removed without causing trauma to the wound (atraumatically).

First, the wound bed is irrigated and cleansed with Actolind Solution Plus. Actolind Gel Plus is then applied for moisturization and protection.

Thanks to its low surface tension and surfactant effect, it disrupts the structure of the biofilm and facilitates its mechanical removal from the wound surface.

Depending on the frequency of dressing changes, it can be safely used 1–3 times daily or at each dressing change.

Yes. The 50 ml, 100 ml, and 250 ml packages with spray nozzles allow the solution to be sprayed directly onto the wound.

By regulating the pH balance of the wound, it helps create an ideal environment conducive to healing.

It is effective against MRSA (methicillin-resistant S. aureus), VRE (vancomycin-resistant enterococci), and resistant Acinetobacter baumannii.

According to tests, it is effective against A. baumannii within 30 seconds and against MRSA, VRE, E. coli, and P. aeruginosa within 5 minutes.

Yes. It demonstrates a yeasticidal effect against Candida albicans with a contact time of 10 minutes.

There is no known development of resistance due to the mechanical/physical mechanism of action of the PHMB contained in the solution.

No. Due to its biocompatible formulation, it does not inhibit (suppress) cell division, epithelialization, or granulation.

Yes. It has been dermatologically tested by Dermatest in Germany and received an “EXCELLENT” rating.

It does not cause sensitization and is very well tolerated by allergic and diabetic patients.

Hypochlorite-based products do not contain surfactants and may degrade rapidly when exposed to light or organic load. Actolind Solution Plus, on the other hand, loosens debris with Poloxamer and provides a long-lasting, stable antimicrobial effect with PHMB.

Octenidine may limit tissue epithelialization in chronic wounds, whereas Actolind Solution Plus is tissue-friendly, does not inhibit epithelialization, and is suitable for continuous use.

Povidone-iodine can cause staining, may irritate tissue, and does not contain a cleansing surfactant. Actolind Solution Plus, on the other hand, is transparent, does not cause a burning sensation, and has a high cleansing capacity.

It is certified as a Class III medical device in accordance with Rule 13 of the 93/42/EEC Medical Device Directive.

It holds ISO 13485, CE marking, ISO 10993-1 biocompatibility certification, and MDR compliance certifications.

It is available in 50 ml, 100 ml, and 250 ml bottles with spray nozzles; 350 ml, 500 ml, and 1000 ml standard bottles; and single-use Monodose strip packs (25 × 5 ml, 10 × 5 ml, etc.).

They eliminate the risk of product contamination after opening and provide convenient, patient-specific use.

Yes. It can be successfully used in conjunction with NPWT devices during wound irrigation and wound bed preparation.

In addition to wound cleansing, it can be used for hygiene of the patient’s dressing areas (Actolind Foam is also available for general body cleansing).

No. This product is not an aesthetic cream or toner intended to remove scars on closed skin; it is a medical irrigation solution designed to promote infection-free closure of open wounds.

No. It is a Class III medically approved wound irrigation product and is not designed for aesthetic facial blemishes or use as a toner.

By promoting faster wound closure, it reduces the frequency of dressing changes, the use of additional consumable materials, infection treatment costs, and the length of hospital stay.

The real cost is not the unit price of the product, but rather the non-healing wound, prolonged treatment duration, resulting complications, and recurring dressing costs. Actolind Solution Plus reduces the total cost by shortening this process.